Kiniksa Pharmaceuticals Stock Performance
as on September 29, 2026 at 6:59 am IST
Day's Low
Day's High
$74.02$76.42
2.77%
Downside
0.38%
Upside
52 Week's Low
52 Week's High
$35.20$82.9453.76%
Downside
8.95%
Upside
Kiniksa Pharmaceuticals share price movements today
- Previous Close
- $75.08
- Open
- $74.56
- Volume
- 489.1K
- Market Cap
- $5.9B
- Day's Low - High
- $74.02 - $76.42
- 52 Week Low - High
- $35.20 - $82.94
Kiniksa Pharmaceuticals Historical Returns
- 1 Month Return
- -3.84 %
- 3 Month Return
- + 26.82 %
- 1 Year Return
- + 105.76 %
- 3 Year Return
- + 331 %
- 5 Year Return
- + 543.91 %
Kiniksa Pharmaceuticals Stock Fundamentals & Key Indicators
Check Kiniksa Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.9B
EPS (TTM)
1.07
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.30%
PE Ratio (TTM)
70.17
Industry PE ratio
24.85
PEG Ratio
0.04168409364300915
EBITDA
112.1M
Revenue (TTM)
840.8M
Profit Margin
54.49%
Return On Equity TTM
13.65%
Kiniksa Pharmaceuticals Stock Valuation
Track how Kiniksa Pharmaceuticals P/E has moved over time to understand its valuation trends.
Kiniksa Pharmaceuticals in the last 5 years
Lowest (-32.97x)
December 31, 2024
Industry (24.85x)
December 31, 2025
Today (51.56x)
December 31, 2025
Highest (87.25x)
December 31, 2023
Today’s Price to Earnings Ratio: 51.56x
Kiniksa Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kiniksa Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $5.9B | 543.91% | 70.17 | 54.49% | 0.00% | |
| Buy | $20.4B | 153.36% | 15.73 | 86.14% | 0.00% | |
| Buy | $20.5B | 30.15% | -49.53 | 34.83% | 2.69% | |
| Buy | $39.9B | NA | 18.89 | 65.57% | 1.34% | |
| Buy | $29.4B | -63.14% | 11.69 | 70.87% | 2.94% |
Stock Returns calculator for Kiniksa Pharmaceuticals Stock including INR - Dollar returns
The Kiniksa Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kiniksa Pharmaceuticals investment value today
Current value as on today
₹2,25,746
Returns
₹1,25,746
(+125.75%)
Returns from Kiniksa Pharmaceuticals Stock
₹1,08,633 (+108.63%)
Dollar Impact
₹17,113 (+17.11%)
Analyst Recommendation on Kiniksa Pharmaceuticals Stock
Based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Kiniksa Pharmaceuticals. Average target price of $98
Kiniksa Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Kiniksa Pharmaceuticals.
What analysts predicted
22.32%UPSIDE
Target Price
$98
Current Price
$76.13
Analyzed by
7 Analysts
High
$107
Target
$98.00
Low
$87
Kiniksa Pharmaceuticals target price $98, a slight upside of 22.32% compared to current price of $76.13. According to 7 analysts rating.
Indian Investors' Interest in Kiniksa Pharmaceuticals Stock
Search interest for Kiniksa Pharmaceuticals Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Kiniksa Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Kiniksa Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Insights on Kiniksa Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, KNSA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, KNSA stock has moved up by 26.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 14.19M → 25.43M (in $), with an average increase of 24.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 10 quarters, 79.85M → 243.59M (in $), with an average increase of 11.4% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, KNSA has outperformed top 5 stocks with highest market-cap in its industry
About Kiniksa Pharmaceuticals
| Organisation | Kiniksa Pharmaceuticals |
| Headquarters | 105 Piccadilly, London, GL, W1J 7NJ, GB |
| Industry | Medical - Pharmaceuticals |
| CEO | Sanj K. Patel |
| E-voting on shares | Click here to vote |
Key Management of Kiniksa Pharmaceuticals
Name | Title |
|---|---|
Mr. Mark A. Ragosa C.F.A. | Executive VP & CFO |
Mr. Ross Michael Moat | Executive VP, COO & Principal Operating Officer |
Mr. Michael R. Megna CPA | Senior VP & Chief Accounting Officer |
Ms. Martina Struck Ph.D. | Senior VP & Chief Regulatory Officer |
Mr. Sanjiv K. Patel | CEO & Chairman of the Board |
Mr. Eben Tessari | Consultant |
Ms. Mei Jang | Senior VP & Chief Technical Officer |
Mr. Jonathan Kirshenbaum | Investor Relations Officer |
Mr. Douglas J. Barry | Senior VP, Chief Legal Officer & Secretary |
Dr. John F. Paolini FACC, M.D., Ph.D. | Executive VP & Chief Medical Officer |
FAQs
What is Kiniksa Pharmaceuticals share price today?
Kiniksa Pharmaceuticals share price today is $76.13 as on at the close of the market. Kiniksa Pharmaceuticals share today touched a day high of $76.42 and a low of $74.02.
What is the 52 week high and 52 week low for Kiniksa Pharmaceuticals share?
Kiniksa Pharmaceuticals share touched a 52 week high of $82.94 on and a 52 week low of $35.20 on . Kiniksa Pharmaceuticals stock price today i.e. is closed at $76.13,which is 8.21% down from its 52 week high and 116.28% up from its 52 week low.
What is Kiniksa Pharmaceuticals's market capitalisation today?
Kiniksa Pharmaceuticals market capitalisation is $0.01T as on .
How to invest in Kiniksa Pharmaceuticals Stock (KNSA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kiniksa Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiniksa Pharmaceuticals Shares that will get you 0.0197 shares as per Kiniksa Pharmaceuticals share price of $76.13 per share as on September 29, 2026 at 1:29 am IST.
What is the minimum amount required to buy Kiniksa Pharmaceuticals Stock (KNSA) from India?
Indian investors can start investing in Kiniksa Pharmaceuticals (KNSA) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Kiniksa Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kiniksa Pharmaceuticals share’s latest price of $76.13 as on September 29, 2026 at 1:29 am IST, you will get 0.1314 shares of Kiniksa Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Kiniksa Pharmaceuticals has given to Indian investors in the last 5 years?
Kiniksa Pharmaceuticals stock has given 543.91% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?